Understanding how organisms tolerate genetic changes caused by transposable elements
Mechanisms and Evolution of Host Tolerance to Transposable Elements
This study looks at how fruit flies deal with pesky bits of DNA that can cause problems in their genes, especially in their egg cells, and it hopes to find out how some genetic changes help them cope, which could also give us clues about human genetics and cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10833078 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which organisms, specifically Drosophila melanogaster, tolerate the genetic disruptions caused by transposable elements, which are segments of DNA that can move around within the genome. The study focuses on understanding how certain genetic variants can help mitigate the harmful effects of these elements, particularly in female reproductive cells. By analyzing genetic mutations and variations, the research aims to uncover the evolutionary history and mechanisms that allow for this tolerance, potentially leading to insights applicable to human genetics and cancer biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic conditions influenced by transposable elements or those at risk for certain cancers related to genetic mutations.
Not a fit: Patients with conditions unrelated to genetic mutations or transposable elements may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of genetic tolerance mechanisms, potentially leading to new strategies for managing genetic diseases and cancers.
How similar studies have performed: While the study of resistance to transposable elements is well-established, the exploration of tolerance mechanisms is relatively novel, indicating a potential for groundbreaking findings.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Kelleher, Erin S — University of Houston
- Study coordinator: Kelleher, Erin S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.